Pulmonary Fibrosis News Forums › Forums › Treatments and Science › Ofev (Nintedanib) › Real World Study Finds IPF Patients with Poor Lung Function Before Starting Ofev Most Likely to Stop Use

  • Ofev (Nintedanib)

    Real World Study Finds IPF Patients with Poor Lung Function Before Starting Ofev Most Likely to Stop Use

    Posted by Pulmonary Fibrosis News Moderator on November 19, 2018 at 5:11 pm

    Real-world U.K. data found poorer lung function at the start of Ofev treatment, plus older age, marked patients with IPF who stopped using it. Click here to read more.

    What do you think about this study and its findings?

    replied 6 years, 7 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .